> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Meditrina 2nd Gen Hysteroscopy System Cleared
- URL: https://www.fdaweb.com/meditrina-2nd-gen-hysteroscopy-system-cleared/
- Published: 2024-05-20T12:00:00.000Z
- Updated: 2026-09-14T14:31:19.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5157018

FDA has cleared a Meditrina 510(k) for its second generation bipolar radiofrequency Aveta Glo hysteroscopy system. “The Aveta System 2.0 builds on the success of its first-generation system, introduced in 2019, allowing physicians full control of procedures from the hysteroscope handle with integrated resection and fluid management,” the company says. “The system is complimented by several pathology-optimized resection devices to treat soft to calcified intrauterine pathologies resulting in 10-minute faster operating room turnover and significantly faster resection time improving the procedural and facility efficiency compared to existing modalities.”

Meditrina says the new system’s bipolar radiofrequency technology allows for more controlled and efficient tissue removal with hemostasis, potentially improving patient outcomes. Additionally, the device enables physicians to address fibroids with deeper myometrial wall penetration across any density tissue type and provide hemostasis when needed, it adds.